{
    "id": 10003,
    "fullName": "IDH1 R132X",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "IDH1 R132X indicates any Idh1 missense mutation that results in the replacement of the arginine (R) at amino acid 132 by a different amino acid. R132 variants are hotspot mutations in Idh1, which often results in conversion of alpha-ketoglutarate to the onco-metabolite 2HG (R(-)-2-hydroxyglutarate) (PMID: 19935646, PMID: 28330869, PMID: 21326614).",
            "references": [
                {
                    "id": 2755,
                    "pubMedId": 21326614,
                    "title": "2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21326614"
                },
                {
                    "id": 487,
                    "pubMedId": 19935646,
                    "title": "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19935646"
                },
                {
                    "id": 9218,
                    "pubMedId": 28330869,
                    "title": "Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28330869"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 3417,
        "geneSymbol": "IDH1",
        "terms": [
            "IDH1",
            "HEL-216",
            "HEL-S-26",
            "IDCD",
            "IDH",
            "IDP",
            "IDPC",
            "PICD"
        ]
    },
    "variant": "R132X",
    "createDate": "08/04/2015",
    "updateDate": "11/01/2019",
    "referenceTranscriptCoordinates": {
        "id": 143871,
        "transcript": "NM_005896",
        "gDna": "chr2:g.208248387_208248389",
        "cDna": "c.394_396",
        "protein": "p.R132",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16857,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, patient-derived acute myeloid leukemia cells harboring IDH1 R132X mutations demonstrated increased sensitivity to CG-806 compared to wild-type cells in culture (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1323).",
            "molecularProfile": {
                "id": 10006,
                "profileName": "IDH1 R132X"
            },
            "therapy": {
                "id": 7038,
                "therapyName": "CG-806",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14956,
                    "pubMedId": null,
                    "title": "CG-806, a pan-FLT3 / pan-BTK inhibitor, demonstrates superior potency against cells from IDH-1 mutant and other non-favorable risk groups of AML patients.",
                    "url": "https://www.aacr.org/Documents/AACR_2019_Proceedings.pdf"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10000,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, IDH305 treatment resulted in objective response in 33% (7/21) of acute myeloid leukemia patients harboring IDH1 R132 mutations, including complete remission in 3 (14%) and partial remission in 4 (19%) patients (Blood 2016 128 (22):1073).",
            "molecularProfile": {
                "id": 10006,
                "profileName": "IDH1 R132X"
            },
            "therapy": {
                "id": 2981,
                "therapyName": "IDH305",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7891,
                    "pubMedId": null,
                    "title": "A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1R132 Mutations",
                    "url": "http://www.bloodjournal.org/content/128/22/1073?sso-checked=true"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10006,
            "profileName": "IDH1 R132X",
            "profileTreatmentApproaches": [
                {
                    "id": 17021,
                    "name": "IDH1 Inhibitor",
                    "profileName": "IDH1 R132X"
                },
                {
                    "id": 17020,
                    "name": "IDH Inhibitor (Pan)",
                    "profileName": "IDH1 R132X"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 143871,
            "transcript": "NM_005896",
            "gDna": "chr2:g.208248387_208248389",
            "cDna": "c.394_396",
            "protein": "p.R132",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 143872,
            "transcript": "NM_001282386",
            "gDna": "chr2:g.208248387_208248389",
            "cDna": "c.394_396",
            "protein": "p.R132",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 143873,
            "transcript": "NM_001282387",
            "gDna": "chr2:g.208248387_208248389",
            "cDna": "c.394_396",
            "protein": "p.R132",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}